Enhancer repertoires are reshaped independently of early priming and heterochromatin dynamics during B cell differentiation

Nature Communications

Volumn 6, Issue , 2015, Pages

  Choukrallah, Mohamed Amin ^a   Song, Shuang ^a   Rolink, Antonius G ^b   Burger, Lukas ^a,c   Matthias, Patrick ^a,b  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS AND CELL COMPONENTS; CHROMOSOME; DEVELOPMENTAL STAGE; DNA; GENETIC ANALYSIS; GENETIC DIFFERENTIATION;

HETEROCHROMATIN; HISTONE; POLYCOMB GROUP PROTEIN;

ANIMAL; B LYMPHOCYTE; C57BL MOUSE; CHROMATIN IMMUNOPRECIPITATION; ENHANCER REGION; EPIGENETICS; GENE SILENCING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HETEROCHROMATIN; METABOLISM;

ANIMALS; B-LYMPHOCYTES; CHROMATIN IMMUNOPRECIPITATION; ENHANCER ELEMENTS, GENETIC; EPIGENOMICS; GENE SILENCING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HETEROCHROMATIN; HISTONES; MICE, INBRED C57BL; POLYCOMB-GROUP PROTEINS;

EID: 84945242289     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9324     Document Type: Article

References (41)

1. Inlay, M. A. et al. Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. Genes Dev. 23, 2376-2381 (2009).
2. Welner, R. S., Pelayo, R., Kincade, P. W. Evolving views on the genealogy of B cells. Nat. Rev. Immunol. 8, 95-106 (2008).
3. Matthias, P., Rolink, A. G. Transcriptional networks in developing and mature B cells. Nat. Rev. Immunol. 5, 497-508 (2005).
4. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).
5. Lin, Y. C. et al. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat. Immunol. 11, 635-643 (2010).
6. Choukrallah, M. A., Matthias, P. The interplay between chromatin and transcription factor networks during B cell development: who pulls the trigger first? Front. Immunol. 5, 156 (2014).
7. Bulger, M., Groudine, M. Functional and mechanistic diversity of distal transcription enhancers. Cell 144, 327-339 (2011).
8. Calo, E., Wysocka, J. Modification of enhancer chromatin: what, how, and why? Mol. Cell 49, 825-837 (2013).
9. Creyghton, M. P. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl Acad. Sci. USA 107, 21931-21936 (2010).
10. Rada-Iglesias, A. et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279-283 (2011).
11. Cao, R. et al. Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science 298, 1039-1043 (2002).
12. Shen, X. et al. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol. Cell 32, 491-502 (2008).
13. Tachibana, M. et al. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev. 19, 815-826 (2005).
14. Hawkins, R. D. et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6, 479-491 (2010).
15. Wen, B., Wu, H., Shinkai, Y., Irizarry, R. A., Feinberg, A. P. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat. Genet. 41, 246-250 (2009).
16. Meshorer, E. et al. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev. Cell 10, 105-116 (2006).
17. Lienert, F. et al. Genomic prevalence of heterochromatic H3K9me2 and transcription do not discriminate pluripotent from terminally differentiated cells. PLoS Genet. 7, e1002090 (2011).
18. Mozzetta, C. et al. The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing. Mol. Cell 53, 277-289 (2014).
19. Revilla, I. D. R. et al. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis. EMBO J. 31, 3130-3146 (2012).
20. Mercer, E. M. et al. Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors. Immunity 35, 413-425 (2011).
21. Cui, K. et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4, 80-93 (2009).
22. Lara-Astiaso, D. et al. Immunogenetics. Chromatin state dynamics during blood formation. Science 345, 943-949 (2014).
23. Luyten, A., Zang, C., Liu, X. S., Shivdasani, R. A. Active enhancers are delineated de novo during hematopoiesis, with limited lineage fidelity among specified primary blood cells. Genes Dev. 28, 1827-1839 (2014).
24. Vigano, M. A. et al. An epigenetic profile of early T-cell development from multipotent progenitors to committed T-cell descendants. Eur. J. Immunol. 44, 1181-1193 (2013).
25. Ruedl, C., Khameneh, H. J., Karjalainen, K. Manipulation of immune system via immortal bone marrow stem cells. Int. Immunol. 20, 1211-1218 (2008).
26. Heintzman, N. D. et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39, 311-318 (2007).
27. Shen, Y. et al. A map of the cis-regulatory sequences in the mouse genome. Nature 488, 116-120 (2012).
28. Hagman, J., Gutch, M. J., Lin, H., Grosschedl, R. EBF contains a novel zinc coordination motif and multiple dimerization and transcriptional activation domains. EMBO J. 14, 2907-2916 (1995).
29. Lin, H., Grosschedl, R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263-267 (1995).
30. Emslie, D. et al. Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor alpha chain expression on activated B cells. J. Exp. Med. 205, 409-421 (2008).
31. Matsuyama, T. et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75, 83-97 (1993).
32. Gerondakis, S., Siebenlist, U. Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harb Perspect. Biol. 2, a000182 (2010).
33. Yue, F. et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature 515, 355-364 (2014).
34. Heintzman, N. D. et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108-112 (2009).
35. Decker, T. et al. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis. Immunity 30, 508-520 (2009).
36. Walter, K., Bonifer, C., Tagoh, H. Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus. Blood 112, 1673-1682 (2008).
37. Maier, H. et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat. Immunol. 5, 1069-1077 (2004).
38. Yamaguchi, T. et al. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev. 24, 455-469 (2010).
39. Gaidatzis, D., Lerch, A., Hahne, F., Stadler, M. B. QuasR: quantification and annotation of short reads in R. Bioinformatics 31, 1130-1132 (2015).
40. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
41. O'connell, J., Hojsgaard, S. Hidden Semi Markov Models for Multiple Observation Sequences: The mhsmm Package for R. J. Stat. Softw. 39, 1-22 (2011).